Literature DB >> 36035617

PINK1: Multiple mechanisms of neuroprotection.

Britney N Lizama1, P Anthony Otero1, Charleen T Chu1,2.   

Abstract

Entities:  

Year:  2021        PMID： 36035617      PMCID： PMC9416918          DOI： 10.1016/bs.irmvd.2021.08.003

Source DB:  PubMed          Journal:  Int Rev Mov Disord        ISSN： 2666-7878


× No keyword cloud information.
  139 in total

1.  Cytosolic cleaved PINK1 represses Parkin translocation to mitochondria and mitophagy.

Authors:  Maja A Fedorowicz; Rosa L A de Vries-Schneider; Cornelia Rüb; Dorothea Becker; Yong Huang; Chun Zhou; Dana M Alessi Wolken; Wolfgang Voos; Yuhui Liu; Serge Przedborski
Journal:  EMBO Rep       Date:  2013-12-15       Impact factor: 8.807

Review 2.  Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds.

Authors:  K F Tipton; T P Singer
Journal:  J Neurochem       Date:  1993-10       Impact factor: 5.372

3.  PINK1 regulates mitochondrial trafficking in dendrites of cortical neurons through mitochondrial PKA.

Authors:  Tania Das Banerjee; Raul Y Dagda; Marisela Dagda; Charleen T Chu; Monica Rice; Emmanuel Vazquez-Mayorga; Ruben K Dagda
Journal:  J Neurochem       Date:  2017-06-23       Impact factor: 5.372

4.  Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study.

Authors:  Eduardo Tolosa; Thierry Vander Borght; Emilio Moreno
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

5.  PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease.

Authors:  Fang Du; Qing Yu; Shijun Yan; Gang Hu; Lih-Fen Lue; Douglas G Walker; Long Wu; Shi Fang Yan; Kim Tieu; Shirley ShiDu Yan
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

6.  Chronic treatment with the complex I inhibitor MPP+ depletes endogenous PTEN-induced kinase 1 (PINK1) via up-regulation of Bcl-2-associated athanogene 6 (BAG6).

Authors:  Manish Verma; Jianhui Zhu; Kent Z Q Wang; Charleen T Chu
Journal:  J Biol Chem       Date:  2020-04-24       Impact factor: 5.157

7.  Characterization of PINK1 processing, stability, and subcellular localization.

Authors:  William Lin; Un Jung Kang
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

8.  Characterization of PINK1 (PTEN-induced putative kinase 1) mutations associated with Parkinson disease in mammalian cells and Drosophila.

Authors:  Saera Song; Seoyeon Jang; Jeehye Park; Sunhoe Bang; Sekyu Choi; Kyum-Yil Kwon; Xiaoxi Zhuang; Eunjoon Kim; Jongkyeong Chung
Journal:  J Biol Chem       Date:  2013-01-09       Impact factor: 5.157

9.  Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.

Authors:  Sun Young Chung; Sarah Kishinevsky; Joseph R Mazzulli; John Graziotto; Ana Mrejeru; Eugene V Mosharov; Lesly Puspita; Parvin Valiulahi; David Sulzer; Teresa A Milner; Tony Taldone; Dimitri Krainc; Lorenz Studer; Jae-Won Shim
Journal:  Stem Cell Reports       Date:  2016-09-15       Impact factor: 7.765

10.  PINK1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1.

Authors:  Raquel Requejo-Aguilar; Irene Lopez-Fabuel; Emilio Fernandez; Luis M Martins; Angeles Almeida; Juan P Bolaños
Journal:  Nat Commun       Date:  2014-07-24       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.